论文部分内容阅读
目的探讨患者-家庭-医院一体化干预治疗对COPD患者生活质量及肺功能的影响。方法将2013年8月—2016年8月在华北理工大学附属医院接受住院治疗的COPD患者154例作为研究对象。将以上研究对象按随机数字表法随机分成对照组和观察组,其中对照组76例,观察组78例。给予对照组患者COPD规范化治疗,而观察组除给予规范化药物治疗外,采用患者-家庭-医院一体化干预治疗模式,应用CAT量表及肺功能检查对二组患者生活质量及肺功能情况进行对比评价。结果观察组治疗后CAT评分明显较治疗前下降(P<0.05),具有统计学意义;对照组治疗后CAT评分较治疗前虽有所下降,但不明显,差异无统计学意义(P>0.05);二组肺功能检查1s用力呼气容积(FEV1)治疗前后无明显改善,差异无统计学意义(P>0.05),但其占预计值的百分比(FEV1%pre)观察组较对照组提高,具有统计学意义(P<0.05)。结论患者-家庭-医院一体化干预治疗可提高COPD患者生活质量,在一定程度上改善肺功能,提高患者对治疗的信心。
Objective To explore the impact of patient-family-hospital integrated intervention on quality of life and lung function in COPD patients. Methods A total of 154 COPD patients hospitalized in Affiliated Hospital of North China Polytechnic University from August 2013 to August 2016 were selected as the study objects. The above subjects were randomly divided into control group and observation group according to random number table method, including 76 cases in control group and 78 cases in observation group. The patients in the control group were given standardized treatment of COPD. In addition to the standardization of drug treatment, the observation group was treated with the integrated mode of patient-family-hospital intervention. The CAT and pulmonary function tests were used to compare the quality of life and pulmonary function in the two groups Evaluation. Results The CAT score of the observation group was significantly lower than that before treatment (P <0.05), which was statistically significant. The CAT score of the control group was lower than that before treatment, but the difference was not statistically significant (P> 0.05 ). There was no significant difference between the two groups before and after forced expiratory volume 1 FEV1 (P> 0.05), but the percentage of the predicted value (FEV1% pre) in the observation group was significantly higher than that of the control group , With statistical significance (P <0.05). Conclusions The patient-family-hospital integrated intervention therapy can improve the quality of life of patients with COPD, improve pulmonary function to a certain extent, and improve patients’ confidence in treatment.